Neuphoria Therapeutics Inc. financial data

Symbol
NEUP on Nasdaq
Location
Burlington, MA
Fiscal year end
30 June
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.87 %
Debt-to-equity 0.47 %
Return On Equity -0.53 % +11.3%
Return On Assets -0.36 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,357,613 shares -99.9%
Common Stock, Shares, Outstanding 2,357,613 shares
Entity Public Float 5,213,998 USD -60.8%
Common Stock, Value, Issued 23 USD
Weighted Average Number of Shares Outstanding, Basic 2,246,066 shares +72.8%
Weighted Average Number of Shares Outstanding, Diluted 2,246,066 shares +72.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 15,000,000 USD
Research and Development Expense 10,889,843 USD +32.3%
General and Administrative Expense 7,973,658 USD +2.7%
Operating Income (Loss) -3,214,053 USD +79.9%
Nonoperating Income (Expense) -6,628,268 USD -2.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9,842,321 USD +10.6%
Income Tax Expense (Benefit) -370,972 USD -1%
Net Income (Loss) Attributable to Parent -9,501,717 USD +12.2%
Earnings Per Share, Basic -4 USD/shares +79.1%
Earnings Per Share, Diluted -4 USD/shares +79.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13,649,638 USD +68.9%
Accounts Receivable, after Allowance for Credit Loss, Current 1,758 USD -98.5%
Assets, Current 13,952,279 USD +65.5%
Property, Plant and Equipment, Net 2,573 USD +31%
Operating Lease, Right-of-Use Asset 75,219 USD -61.9%
Intangible Assets, Net (Excluding Goodwill) 4,639,108 USD -12.5%
Goodwill 8,674,734 USD -2.6%
Assets 27,343,913 USD +19.3%
Accounts Payable, Current 1,370,728 USD +3.4%
Liabilities, Current 5,124,276 USD +1%
Deferred Income Tax Liabilities, Net 460,320 USD -44.6%
Operating Lease, Liability, Noncurrent 19,322 USD
Other Liabilities, Noncurrent 3,647 USD
Liabilities 14,833,726 USD +1.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2,795,845 USD -15.1%
Retained Earnings (Accumulated Deficit) -188,253,207 USD -5.3%
Stockholders' Equity Attributable to Parent 12,510,187 USD -26.7%
Liabilities and Equity 27,343,913 USD +19.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3,794,648 USD +14.4%
Net Cash Provided by (Used in) Financing Activities 3,253,615 USD
Common Stock, Shares Authorized 30,000,000 shares
Common Stock, Shares, Issued 2,357,613 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -560,488 USD +87.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13,728,202 USD +68.1%
Deferred Tax Assets, Valuation Allowance 26,139,160 USD -5.6%
Deferred Tax Assets, Gross 26,956,776 USD -5%
Operating Lease, Liability 85,210 USD -61.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9,838,980 USD +2.9%
Lessee, Operating Lease, Liability, to be Paid 145,275 USD
Property, Plant and Equipment, Gross 47,716 USD -0.09%
Operating Lease, Liability, Current 85,210 USD -34.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 182,854 USD
Lessee, Operating Lease, Liability, to be Paid, Year One 119,593 USD -38.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2,457 USD -97.7%
Preferred Stock, Shares Authorized 3,000,000 shares
Additional Paid in Capital 203,559,216 USD +2.7%
Deferred Tax Assets, Net of Valuation Allowance 26,100,000 USD -5.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares